May 26, 2020
As per the report titled ‘Cardiac Ablation Market Size By Product, By Application, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026’, available with Market Study Report LLC, global cardiac ablation market is expected to grow momentously through 2026.
Cardiac ablation is a procedure that involves scarring or destroying of heart tissues which allow passage of wrong electric signals leading to abnormal heart rhythm known as cardiac arrhythmia. Increased pervasiveness of cardiovascular diseases across the globe, rising geriatric population who are more prone to these diseases, and technological advancements in ablation devices are among the major growth drivers of global cardiac ablation industry.
Based on the product type, electric ablators are experiencing a high demand as these devices are used for momentary intracardiac sensing, recording & mapping, stimulation, and as minimally invasive treatment.
Elaborating on the application scope, cardiac rhythm management segment is anticipated to observe significant gains during the assessment period. Cardiac rhythm management comprises of atrial fibrillation & flutter and tachycardia. Rising prevalence of atrial fibrillation among the geriatric populace is boosting product adoption. Treatments such as cardioversion can restore normal heart rhythm, creating an upsurge in the demand for atrial fibrillation procedures for cardiac rhythm management. Moreover, favorable reimbursement scenario for these medical procedures is expected to enhance the segment growth.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2525388/
Speaking of the end-use spectrum, cardiac ablation market share from electrophysiology labs segment is expected to show considerable growth during the analysis period. These labs have advanced equipment designed to map and monitor the electrical systems of the heart along with treating heart rhythms complications associated with arrhythmias. Sophisticated procedures like cardiac ablation, cardiac mapping, and device insertion are performed in these labs. This factor coupled with increase in number of patients suffering from cardiac arrhythmias and availability of long-term treatments which require routine checkup are aiding the popularity of electrophysiology labs.
Considering the geographical landscape, Latin America cardiac ablation market is expected to witness strong growth over the forecast timeline with Brazil at the forefront. Rising awareness about various cardiac ablation procedures and increasing cases of cardiovascular ailments in the region are driving the regional market growth.
Prominent industry players include AngioDynamics, Inc., Abbott Laboratories (St. Jude Medical), AtriCure Inc., Biotronik SE & Co. KG, Biosense Webster (Johnson & Johnson), Boston Scientific Corporation, Medtronic plc, Japan Lifeline, Stereotaxis, Inc., and MicroPort Scientific Corporation.